Cytogenetic study of Brazilian patients with myelodysplastic syndrome (MDS)

被引:3
|
作者
Borgonovo, Tamara
Ribeiro, Enilze M. S. F.
Cornelio, Deborah Afonso
Schmid-Braz, Ana Teresa
Jamur, Valderez Ravaglio
Wuicik, Lismeri
Acosta Veiga, Loraine Beatriz
Ehmke, Neria A. Maia
Pasquini, Ricardo
Cavalli, Iglenir Joao
机构
[1] Univ Fed Parana, Dept Genet, Lab Citogenet Humana, BR-81531970 Curitiba, Parana, Brazil
[2] Univ Fed Parana, Hosp Clin, Lab Citogenet & Imunogenet, BR-81531970 Curitiba, Parana, Brazil
[3] Univ Fed Parana, Hosp Clin, Serv Transplante Medula Ossea, BR-81531970 Curitiba, Parana, Brazil
关键词
hematological disorders; myelodysplasias; cancer cytogenetics;
D O I
10.1590/S1415-47572005000500002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone marrow cytogenetic studies were performed on 93 patients with primary myelodysplastic syndrome (MDS) diagnosed at the Clinical Hospital of the Federal University of Parana, Brazil. Chromosomal alterations were observed in 69% of the patients. Monosomy of chromosome 7, deletions of 7q, 5q, 12p and 20q, rearrangements of 11q23 and trisomies of chromosomes 8 and 21 were the most frequent abnormalities observed. Among adult patients the most frequent aberrations were rearrangements of 11q23 and 12p deletions. In the pediatric group, 5q deletions and monosomy of chromosome 7 were the most common alterations.
引用
收藏
页码:654 / 660
页数:7
相关论文
共 50 条
  • [21] Distribution of lipid rafts at patients with myelodysplastic syndrome (MDS)
    Schiller, Joanna
    Kuliszkiewicz-Janus, Malgorzata
    Marc, Maciek
    Lach, Agnieszka
    CHEMISTRY AND PHYSICS OF LIPIDS, 2010, 163 : S60 - S61
  • [22] Has cytogenetic evolution any prognostic relevance in myelodysplastic syndromes (MDS)? A study on 153 patients.
    Bernasconi, Paolo
    Klersy, Catherine
    Boni, Marina
    Cavigliano, Paola Maria
    Calatroni, Silvia
    Giardini, Ilaria
    Rocca, Barbara
    Zappatore, Rita
    Dambruoso, Irene
    Caresana, Marilena
    Lazzarino, Mario
    BLOOD, 2007, 110 (11) : 725A - 726A
  • [23] CYTOGENETIC CHARACTERIZATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) FROM 'ANDROMEDA' NETWORKING PROJECT
    Albano, F.
    Di Renzo, N.
    Pavone, V.
    Guarini, A.
    Tarantini, G.
    Capalbo, S.
    Iannitto, E.
    Cascavilla, N.
    Quarta, G.
    Ditonno, P.
    Polimeno, G.
    Casieri, P.
    Specchia, G.
    HAEMATOLOGICA, 2012, 97 : 139 - 139
  • [24] Cytogenetic and clonal profile of myelodysplastic syndromes (MDS) patients treated with thalidomide.
    Alvi, S
    Shaikh, M
    Anthwal, S
    Shaher, A
    Tamoseviciene, D
    Novick, A
    Reddy, P
    Allampallam, K
    Hsu, WT
    Galili, N
    Borok, RZ
    Raza, A
    BLOOD, 2001, 98 (11) : 352A - 352A
  • [25] Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia
    Feldman, EJ
    Seiter, KP
    Ahmed, T
    Baskind, P
    Arlin, ZA
    LEUKEMIA, 1996, 10 (01) : 40 - 42
  • [26] APOPTOSIS IN MYELODYSPLASTIC SYNDROME (MDS)
    GREENBERG, PL
    GINZTON, N
    RAJAPAKSA, R
    TONG, CR
    HAN, JH
    BLOOD, 1993, 82 (10) : A43 - A43
  • [27] Cytogenetic features and prognosis analysis in Chinese patients with myelodysplastic syndrome: a multicenter study
    Wang, Hong
    Wang, XiaoQin
    Xu, XiaoPing
    Lin, GuoWei
    ANNALS OF HEMATOLOGY, 2010, 89 (06) : 535 - 544
  • [28] Cytogenetic features and prognosis analysis in Chinese patients with myelodysplastic syndrome: a multicenter study
    Hong Wang
    XiaoQin Wang
    XiaoPing Xu
    GuoWei Lin
    Annals of Hematology, 2010, 89 : 535 - 544
  • [29] Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients
    Yilmaz, Z
    Sahin, FI
    Kizilkilic, E
    Karakus, S
    Boga, C
    Özdogu, H
    CLINICAL AND EXPERIMENTAL MEDICINE, 2005, 5 (02) : 55 - 59
  • [30] Cytogenetic Features in Primary Myelodysplastic Syndrome Egyptian Patients
    Elnahass, Yasser
    Talaat, Lamia
    Elreafey, Fatma
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S343 - S343